American Well Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by American Well Corporation on April 2, 2026, regarding an event dated April 1, 2026. The company is incorporated in Delaware and its Class A Common Stock trades on the New York Stock Exchange under the symbol AMWL.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. Dr. Peter Slavin notified the Company of his resignation from the Board of Directors, effective at the next annual meeting of stockholders in 2026. He will continue to serve until that meeting. The resignation is attributed to his transition to a new role on the West Coast and is explicitly stated not to be the result of any disagreement with the Company regarding operations, policies, or procedures.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No risks, contingencies, or unusual items are disclosed in this specific report.
Key Facts for Investor Verification
- Dr. Peter Slavin is resigning from the Board of Directors after more than nine years of service.
- The resignation is effective at the 2026 annual meeting of stockholders.
- The departure is due to a personal career transition and not a disagreement with the Company.
- Dr. Slavin will remain on the Board until the annual meeting concludes.